BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4330662)

  • 1. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4283482
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
    Hetrick C; Ras R; Turri M
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1830-3. PubMed ID: 5453003
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin with ethambutol for drug-resistant tuberculosis.
    Pines A
    Br J Dis Chest; 1971 Jul; 65():178-81. PubMed ID: 4997816
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
    Tubercle; 1976 Jun; 57(2):105-13. PubMed ID: 822547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy of pulmonary tuberculosis using rifampicin and ethambutol].
    Haegi V
    Helv Med Acta Suppl; 1969; 49():81-7. PubMed ID: 5267584
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.